Literature DB >> 8920890

Surrogate or conventional light chains are required for membrane immunoglobulin mu to activate the precursor B cell transition.

F Papavasiliou1, M Jankovic, M C Nussenzweig.   

Abstract

To examine the role of light chains in early B cell development we combined RAG-1 and lambda 5 mutations to produce mice that expressed neither conventional nor surrogate light chains (RAG-1-/-, lambda 5-/-). Unique heavy and light chain genes were then introduced into the double and single mutant backgrounds. Membrane immunoglobulin (Ig)mu (mIg mu) associated with Ig alpha-Ig beta but was unable to activate the pre-B cell transition in RAG-1-/-lambda 5-/- mice. Either lambda 5 or kappa light chains were sufficient to complement this deficiency. Therefore light chains are absolutely required for a functional Ig signaling module in early B cell development. Our data provide direct evidence for the existence of two pathways for induction of early B cell development: one which is activated through surrogate light chains and mIg mu, and an alternative pathway which uses conventional light chains and mIg mu.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920890      PMCID: PMC2192894          DOI: 10.1084/jem.184.5.2025

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  A mouse myeloma variant with a defect in light chain synthesis.

Authors:  S L Morrison; M D Scharff
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

2.  In vitro transformation of lymphoid cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

Review 3.  Clonal selection and learning in the antibody system.

Authors:  K Rajewsky
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

4.  Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain.

Authors:  S Pillai; D Baltimore
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

5.  B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells.

Authors:  G G Hermanson; D Eisenberg; P W Kincade; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Heavy chain-producing variants of a mouse myeloma cell line.

Authors:  S L Morrison; M D Scharff
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

7.  Immunoglobulin heavy chain binding protein.

Authors:  I G Haas; M Wabl
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

Review 8.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

9.  Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu.

Authors:  M C Nussenzweig; A C Shaw; E Sinn; D B Danner; K L Holmes; H C Morse; P Leder
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

10.  Control of immunoglobulin secretion in the murine plasmacytoma line MOPC 315.

Authors:  G E Sonenshein; M Siekevitz; G R Siebert; M L Gefter
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  11 in total

1.  Efficient generation of B lymphocytes by recognition of self-antigens.

Authors:  Cathrin Eschbach; Martina P Bach; Ingrid Fidler; Roberta Pelanda; Fabian Köhler; Klaus Rajewsky; Hassan Jumaa
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

2.  Differential effect of an Ig mu transgene on development of pre-B cells in fetal and adult SCID mice.

Authors:  G C Bosma; Y Chang; H Karasuyama; M J Bosma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 3.  Role of the BCR complex in B cell development, activation, and leukemic transformation.

Authors:  Susan R Rheingold; Valerie I Brown; Junjie Fang; Jenny M Kim; Stephan A Grupp
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production.

Authors:  José Luis Vela; Djemel Aït-Azzouzene; Bao Hoa Duong; Takayuki Ota; David Nemazee
Journal:  Immunity       Date:  2008-02-07       Impact factor: 31.745

5.  Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor.

Authors:  J Hess; A Werner; T Wirth; F Melchers; H M Jäck; T H Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

6.  Loss of precursor B cell expansion but not allelic exclusion in VpreB1/VpreB2 double-deficient mice.

Authors:  C Mundt; S Licence; T Shimizu; F Melchers; I L Mårtensson
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

7.  Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia.

Authors:  Y Minegishi; E Coustan-Smith; Y H Wang; M D Cooper; D Campana; M E Conley
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

8.  Extended duration of DH-JH rearrangement in immunoglobulin heavy chain transgenic mice: implications for regulation of allelic exclusion.

Authors:  Y Chang; M J Bosma; G C Bosma
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

9.  Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis.

Authors:  C Thévenin; S L Nutt; M Busslinger
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

10.  Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models.

Authors:  Ming Tian; Kelly McGovern; Hwei-Ling Cheng; Peyton Waddicor; Lisa Rieble; Mai Dao; Yiwei Chen; Michael T Kimble; Elizabeth Cantor; Nicole Manfredonia; Rachael Judson; Aimee Chapdelaine-Williams; Derek W Cain; Barton F Haynes; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-24       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.